I know it's not quite a silver bullet but it has really positive results compared to others...two part question

1) if we currently had 20 million doses of Remdesivir available would you be less anxious about reopening? and would you go so far as a more expedited reopening?

2) If on Dec 1st we had 20 Million doses of Remdesivir and we knew early intervention was key (along with the understanding that ventilators were not the answer)....how many of the ~60k deaths would have been avoided? Could we have kept it to 30,000? 20,000?

https://www.bloomberg.com/opinion/articles/2020-05-01/coronavirus-gilead-s-remdesivir-trial-missed-a-huge-opportunity

Meh, pretty crappy article. Gilead has multiple ongoing trials and plans to answer the questions the author raises. The results released this week was an NIAID funded adaptive design trial, and they only released top-line results after their Data Safety Monitoring Board saw the significant reduction in time to improvement. Trust that there will be subgroup analyses, and that there will be a lot more information coming from the Gilead-sponsored trials.

Hope so, otherwise only moderately optimistic.

They have enough manufacturing capacity and raw material to have 140,000 total courses of treatment available by the end of May. Right now they have about 30,000.

They are investigating whether a shorter course of treatment could be as effective so that more people can be treated.

https://www.gilead.com/purpose/advancing-global-health/covid-19/working-to-supply-remdesivir-for-covid-19